drugset / Trial / NCT01076335
Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find out if a therapy using docetaxel chemotherapy with hormonal therapy taken before your scheduled surgery is beneficial to treatment of prostate cancer. The safety of this combination will also be studied.
Timeline
- Start
- 2005-05
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 35 mg/m2 | Intravenous |
| Subject | Goserelin | Other / unclassified | — | — |
| Subject | Leuprolide | Other / unclassified | — | — |